Surprising Analyst 12-Month Target For PBUS

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco PureBeta MSCI USA ETF (Symbol: PBUS), we found that the implied analyst target price for the ETF based upon its underlying holdings is $49.94 per unit.

With PBUS trading at a recent price near $45.40 per unit, that means that analysts see 10.00% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of PBUS's underlying holdings with notable upside to their analyst target prices are Elanco Animal Health Inc (Symbol: ELAN), Zscaler Inc (Symbol: ZS), and American Financial Group Inc (Symbol: AFG). Although ELAN has traded at a recent price of $32.92/share, the average analyst target is 11.38% higher at $36.67/share. Similarly, ZS has 11.22% upside from the recent share price of $275.80 if the average analyst target price of $306.74/share is reached, and analysts on average are expecting AFG to reach a target price of $143.50/share, which is 10.97% above the recent price of $129.32. Below is a twelve month price history chart comparing the stock performance of ELAN, ZS, and AFG:

ELAN, ZS, and AFG Relative Performance Chart

Below is a summary table of the current analyst target prices discussed above:

.hctblstyle { font-family: Arial; font-size: 12px; width: 100%; }.hctblstyle th { padding: 2px; border-bottom: 1px solid #999999; background-color: #EFEFEF; }.hctblstyle td { padding: 2px; border-bottom: 1px solid #AAAAAA; background-color: #FEFEFE; }

Name Symbol Recent Price Avg. Analyst 12-Mo. Target % Upside to Target
Invesco PureBeta MSCI USA ETF PBUS $45.40 $49.94 10.00%
Elanco Animal Health Inc ELAN $32.92 $36.67 11.38%
Zscaler Inc ZS $275.80 $306.74 11.22%
American Financial Group Inc AFG $129.32 $143.50 10.97%

Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research.

10 ETFs With Most Upside To Analyst Targets »

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Other Topics

Stocks ETFs

Latest Markets Videos

    BNK Invest

    BNK Invest Inc. provides investment services and information. BNK Invest owns and operates a market news family of websites including DividendChannel, ETFChannel, StockOptionsChannel, and others, which make up an investor community featuring stock message boards, ratings, research, and strategies. BNK Invest caters to investing firms and individual investors internationally.

    Learn More